抄録
A second polymorphic form of the antileishmanial 7-methoxy-4-[(E)-oct-1-enyl]pyrrolo[1,2-a]quinoxaline was established. This second form crystallizes in the triclinic space group P1. In addition to the previous results, these new data could be further used to clarify the mechanism of action, implicating this antileishmanial synthetic compound.